Practical considerations for nonclinical safety evaluation of therapeutic monoclonal antibodies

Practical considerations for nonclinical safety evaluation of therapeutic monoclonal antibodies

Item
http://www.wikidata.org/entity/Q27690917
Generation and characterization of a unique reagent that recognizes a panel of recombinant human monoclonal antibody therapeutics in the presence of endogenous human IgGSafety and immunotoxicity assessment of immunomodulatory monoclonal antibodiesA monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivityNeutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.Bridging the gap: facilities and technologies for development of early stage therapeutic mAb candidatesTargeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy.Nonclinical strategy considerations for safety pharmacology: evaluation of biopharmaceuticals.Society of Toxicologic Pathology position paper on best practices on recovery studies: the role of the anatomic pathologist.Optimized nonclinical safety assessment strategies supporting clinical development of therapeutic monoclonal antibodies targeting inflammatory diseases.The development of therapeutic monoclonal antibodies: overview of the nonclinical safety assessment.A Pharmacokinetic and Safety Study of Trebananib, an Fc-Fusion Peptibody, in Patients With Advanced Solid Tumors and Varying Degrees of Renal Dysfunction.Regulatory Pathway for Licensing Biotherapeutics in Mexico
P2860

Practical considerations for nonclinical safety evaluation of therapeutic monoclonal antibodies

Item
http://www.wikidata.org/entity/Q27690917
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Practical considerations for n ...... rapeutic monoclonal antibodies
@ast
Practical considerations for n ...... rapeutic monoclonal antibodies
@en
Practical considerations for n ...... apeutic monoclonal antibodies.
@nl
type
label
Practical considerations for n ...... rapeutic monoclonal antibodies
@ast
Practical considerations for n ...... rapeutic monoclonal antibodies
@en
Practical considerations for n ...... apeutic monoclonal antibodies.
@nl
prefLabel
Practical considerations for n ...... rapeutic monoclonal antibodies
@ast
Practical considerations for n ...... rapeutic monoclonal antibodies
@en
Practical considerations for n ...... apeutic monoclonal antibodies.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Practical considerations for n ...... rapeutic monoclonal antibodies
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932